ONA strongly criticized the Trump administration's decision to dissolve the CDC Healthcare Infection Control Practices ...

A new study from an international team of researchers, including those from UC San Diego’s School of Medicine, gives new credence to the theory that the COVID-19 pandemic spread naturally by ...

Learn more about whether Moderna, Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo ...

Learn more about whether Catalyst Pharmaceuticals, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor ...

Moderna’s study, involving 8,000 adults 50 and older, showed the new combo shot generated an immune response against COVID and most strains of flu compared to existing stand-alone shots.

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...

The overall uptake of RSV vaccine is low during its first season in those aged 60 years or older in the United States. The knowledge of the vaccine and its eligibility is limited.